B. Hofstad et al., GROWTH AND RECURRENCE OF COLORECTAL POLYPS - A DOUBLE-BLIND 3-YEAR INTERVENTION WITH CALCIUM AND ANTIOXIDANTS, Digestion, 59(2), 1998, pp. 148-156
Background: Dietary calcium and antioxidants have been suggested as pr
otective agents against colorectal cancer. This has been supported by
animal experimental studies, case control and cohort studies. Material
s and Methods: In a prospective intervention study of colorectal adeno
mas, and intermediary stage in colorectal carcinogenesis, 116 polyp-be
aring patients received a placebo-controlled daily mixture of beta-car
otene 15 mg, vitamin C 150 mg, vitamin E 75 mg, selenium 101 mu g, and
calcium (1.6 g daily) as carbonate for a period of 3 years with annua
l colonoscopic follow-up to test if the mixture was able to reduce pol
yp growth or recurrence. All polyps of <10 mm at enrolment or follow-u
p were left unresected until the end of the study. Results: 87-91% of
the patients attended the annual endoscopic follow-up investigations:
and 19% of the patients dropped out of the medical intervention. The r
est consumed 85% of the total amount of tablets over the 3 years. The
fecal calcium concentration was 2.3-2.7 times higher in patients takin
g active medication compared to the placebo group. Diet registration s
howed that, when adding the intake of antioxidants and calcium from di
et and intervention, there was a significant difference between the in
take of these substances in the active and the placebo group. No diffe
rence was detected in the growth of adenomas between the active and th
e placebo group from year to year and for the total study period. More
over, there was no effect on polyps of <5 or 5-9 mm, Or on polyps in t
he different colonic segments analyzed separately. A reduced growth of
adenomas was found in patients <60 years of age taking active medicat
ion (n = 8) compared to those taking placebo (n = 6 mean difference 2.
3 mm; 95% CI 0.26-4.36). There was a significantly lower number of pat
ients free of new adenomas in the placebo group compared to those taki
ng active medication as tested by logistic regression and Kaplan-Meier
analysis clog-rank test p value 0.035). Subgroup analysis showed that
only the group of patients with no family history of colorectal cance
r, those with only one adenoma at inclusion, and those <65 years benef
itted from the intervention medication. Conclusion: The study did not
find an overall effect on polyp growth, Our data, however, may support
a protective role of calcium and antioxidants on new adenoma formatio
n.